Lantheus (LNTH) Competitors $86.45 +7.02 (+8.84%) (As of 11/20/2024 ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends LNTH vs. RIOT, NEOG, QDEL, CLDX, VIVO, TEVA, BGNE, VTRS, SMMT, and MRNAShould you be buying Lantheus stock or one of its competitors? The main competitors of Lantheus include Riot Platforms (RIOT), Neogen (NEOG), QuidelOrtho (QDEL), Celldex Therapeutics (CLDX), Meridian Bioscience (VIVO), Teva Pharmaceutical Industries (TEVA), BeiGene (BGNE), Viatris (VTRS), Summit Therapeutics (SMMT), and Moderna (MRNA). Lantheus vs. Riot Platforms Neogen QuidelOrtho Celldex Therapeutics Meridian Bioscience Teva Pharmaceutical Industries BeiGene Viatris Summit Therapeutics Moderna Riot Platforms (NASDAQ:RIOT) and Lantheus (NASDAQ:LNTH) are both mid-cap business services companies, but which is the superior business? We will contrast the two companies based on the strength of their dividends, media sentiment, risk, valuation, institutional ownership, earnings, analyst recommendations, community ranking and profitability. Do institutionals and insiders believe in RIOT or LNTH? 40.3% of Riot Platforms shares are held by institutional investors. Comparatively, 99.1% of Lantheus shares are held by institutional investors. 6.9% of Riot Platforms shares are held by insiders. Comparatively, 2.1% of Lantheus shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth. Does the media favor RIOT or LNTH? In the previous week, Lantheus had 4 more articles in the media than Riot Platforms. MarketBeat recorded 7 mentions for Lantheus and 3 mentions for Riot Platforms. Lantheus' average media sentiment score of 1.02 beat Riot Platforms' score of 0.88 indicating that Lantheus is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Riot Platforms 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 1 Very Negative mention(s) Positive Lantheus 5 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Do analysts rate RIOT or LNTH? Riot Platforms currently has a consensus target price of $16.35, indicating a potential upside of 34.57%. Lantheus has a consensus target price of $122.50, indicating a potential upside of 41.70%. Given Lantheus' higher possible upside, analysts plainly believe Lantheus is more favorable than Riot Platforms.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Riot Platforms 0 Sell rating(s) 0 Hold rating(s) 10 Buy rating(s) 1 Strong Buy rating(s) 3.09Lantheus 0 Sell rating(s) 1 Hold rating(s) 8 Buy rating(s) 0 Strong Buy rating(s) 2.89 Does the MarketBeat Community prefer RIOT or LNTH? Riot Platforms received 181 more outperform votes than Lantheus when rated by MarketBeat users. Likewise, 68.29% of users gave Riot Platforms an outperform vote while only 65.89% of users gave Lantheus an outperform vote. CompanyUnderperformOutperformRiot PlatformsOutperform Votes51968.29% Underperform Votes24131.71% LantheusOutperform Votes33865.89% Underperform Votes17534.11% Which has stronger valuation & earnings, RIOT or LNTH? Lantheus has higher revenue and earnings than Riot Platforms. Riot Platforms is trading at a lower price-to-earnings ratio than Lantheus, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioRiot Platforms$312.91M12.90-$49.47M$1.518.05Lantheus$1.30B4.64$326.66M$6.0114.38 Which has more risk & volatility, RIOT or LNTH? Riot Platforms has a beta of 4.08, suggesting that its stock price is 308% more volatile than the S&P 500. Comparatively, Lantheus has a beta of 0.51, suggesting that its stock price is 49% less volatile than the S&P 500. Is RIOT or LNTH more profitable? Riot Platforms has a net margin of 115.35% compared to Lantheus' net margin of 28.57%. Lantheus' return on equity of 44.29% beat Riot Platforms' return on equity.Company Net Margins Return on Equity Return on Assets Riot Platforms115.35% 14.89% 14.01% Lantheus 28.57%44.29%23.52% SummaryLantheus beats Riot Platforms on 10 of the 19 factors compared between the two stocks. Ad DarwinNew Year, New Opportunity! 2 AI Stocks Under $10 Ready to SoarAs we step into 2025, artificial intelligence (AI) stocks continue to dominate headlines, and now is the perfect moment to position yourself for the coming year’s potential. Our latest research has uncovered two must-buy AI stocks currently trading under $10/share – an affordable entry with promising growth potential. These stocks are flying under the radar, but it’s only a matter of time before they gain mainstream attention.👉 Click here to access your FREE report now! Get Lantheus News Delivered to You Automatically Sign up to receive the latest news and ratings for LNTH and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart LNTH vs. The Competition Export to ExcelMetricLantheusDiagnostic substances IndustryMedical SectorNASDAQ ExchangeMarket Cap$6.01B$2.52B$5.04B$8.81BDividend YieldN/A0.76%5.16%4.07%P/E Ratio14.386.08130.5317.82Price / Sales4.6430.871,183.8674.55Price / Cash11.3916.3433.6132.53Price / Book7.263.004.684.68Net Income$326.66M$29.98M$119.23M$226.08M7 Day Performance6.94%-1.26%-1.83%-1.04%1 Month Performance-22.87%-9.92%-3.61%1.04%1 Year Performance26.91%-14.62%31.74%26.28% Lantheus Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)LNTHLantheus4.5262 of 5 stars$86.45+8.8%$122.50+41.7%+25.1%$6.01B$1.30B14.38834Positive NewsGap UpRIOTRiot Platforms4.1524 of 5 stars$12.15-1.0%$16.35+34.6%+7.3%$4.08B$312.91M8.05340Insider TradeGap UpNEOGNeogen2.153 of 5 stars$14.90-1.3%$17.50+17.4%-8.5%$3.27B$924.22M0.002,640QDELQuidelOrtho4.5798 of 5 stars$37.48-2.9%$58.83+57.0%-45.1%$2.59B$3.00B0.007,100Analyst ForecastGap DownHigh Trading VolumeCLDXCelldex Therapeutics2.8776 of 5 stars$26.40+5.7%$62.25+135.8%-3.0%$1.66B$6.88M0.00160Analyst ForecastNews CoverageVIVOMeridian Bioscience1.0351 of 5 stars$33.97flatN/AN/A$1.50B$333.02M35.02702Analyst ForecastTEVATeva Pharmaceutical Industries2.6924 of 5 stars$17.03+1.2%$19.67+15.5%+80.0%$19.04B$15.85B0.0037,851BGNEBeiGene3.174 of 5 stars$194.26+3.5%$247.07+27.2%+3.4%$18.92B$2.46B-23.5810,600Analyst DowngradeGap UpVTRSViatris1.3448 of 5 stars$13.13+0.6%$13.33+1.5%+38.6%$15.58B$15.43B0.0038,000SMMTSummit Therapeutics1.863 of 5 stars$18.62-6.9%$34.75+86.6%+835.7%$14.75B$700,000.000.00105Analyst ForecastMRNAModerna4.6267 of 5 stars$36.94-0.9%$84.00+127.4%-53.2%$14.35B$6.85B0.005,600Analyst UpgradeAnalyst Revision Related Companies and Tools Related Companies RIOT Competitors NEOG Competitors QDEL Competitors CLDX Competitors VIVO Competitors TEVA Competitors BGNE Competitors VTRS Competitors SMMT Competitors MRNA Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:LNTH) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredElon knows the truth, which is why they want him silencedElon Musk is one of mankind’s greatest innovators. But for all his visionary prowess and contributions to h...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Lantheus Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Lantheus With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.